Khalil Katato

Prostate cancer therapy personalization via multi-modal deep learning on randomized phase III clinical trials

Andre Esteva, Jean Feng, Douwe van der Wal et al. · npj Digital Medicine · 2022 · 197 citations · Full text

Medicine, Oncology, Urology +17

Establishment of a human B-CLL xenograft model: utility as a preclinical therapeutic model.

Ramzi M. Mohammad, Arredouani Mohamed, Mohamed Y. Hamdan et al. · PubMed · 1996 · 41 citations

Medicine, Translational Sciences, Molecular Oncology +6

Sequential treatment of human chronic lymphocytic leukemia with bryostatin 1 followed by 2-chlorodeoxyadenosine: preclinical studies.

Ramzi M. Mohammad, Khalil Katato, Victor P. Almatchy et al. · PubMed · 1998 · 37 citations

Medicine, Oncology, Pharmacology +13

Potentiation of 2-Chlorodeoxyadenosine Activity by Bryostatin 1 in the Resistant Chronic Lymphocytic Leukemia Cell Line (WSU-CLL): Association with Increased Ratios of dCK/5'-NT and Bax/Bcl-2

Ramzi M. Mohammad, Frances W.J. Beck, Khalil Katato et al. · Biological Chemistry · 1998 · 32 citations

Medicine, Cancer Biology, Oncology +13

Aspirin for venous thromboembolism prophylaxis after hip or knee arthroplasty: An updated meta-analysis of randomized controlled trials

Tarek Haykal, Babikir Kheiri, Yazan Zayed et al. · Journal of Orthopaedics · 2019 · 31 citations · Full text

Medicine, Orthopaedic Surgery, Orthopedic Surgery +16